Julie Schiffman is the Senior Vice President of Scientific Engagement and Delivery at Aetion. Previously, she spent 17 years at Pfizer working on both the commercial and R&D sides of the business to improve overall R&D productivity and get treatments to patients faster, and at a lower cost. Most recently, Julie was the Vice President, Global Business Analytics, where she led a 350-person data and analytics team as they ran analyses to drive Pfizer’s business and portfolio forward. Prior to Pfizer, Julie spent time consulting at Deloitte. She received her B.A. from Brown University, and her M.B.A. from the Wharton School.